AKT1 and asthma: Liu et al. (Liu et al., 2020) found that lncRNA CASC7 inhibits the PI3K/Akt signalling pathway by targeting miR-21 and promotes the phosphorylation of glucocorticoid receptors to increase the sensitivity of glucocorticoids in patients with severe asthma.